Abstract: A connector for medical fluid vessels includes a fluid-seal fitting such as a male plug defining a lumen and mating with a cooperating connector, a mechanical fastener such as a screw thread for mating with the cooperating connector, and an outer housing positioned around the plug to form an annular space. A cap can be provided with a fluid-seal fitting such as a male plug for mating with the lumen of the connector. In example embodiments, the male plug is tapered and can comprise one or more projections for sealingly engaging with the lumen of the connector. According to some example embodiments, the cap can be tethered to the connector.

Abstract: Provided herein is a ligament ECM soluble fraction useful for the growth and regrowth of ligament tissue. Methods of preparation of the soluble fractions and use of the soluble fractions in growth or regrowth of ligament tissue also are provided.

Abstract: Provided herein is a ligament ECM soluble fraction useful for the growth and regrowth of ligament tissue. Methods of preparation of the soluble fractions and use of the soluble fractions in growth or regrowth of ligament tissue also are provided.

Abstract: A slide assembly for a ladder rack may be adapted to selectively move with respect to a rail. The assembly may have first and second slide walls connected together by an intermediate rail slide wall and at least one fastener, where the at least one fastener may be adapted to be slidably received within the rail. The assembly may also have a support flange connected to the second rail slide wall. The assembly may also have a housing connected to the support flange, where a retention tube is rotatably mounted within the housing. A first gripper member may be connected to the retention tube for selective movement therewith.

Abstract: Compounds are presented having the formula [M4L6].Xn, where M is a transition metal ion having 6 d-shell valence electrons, X is a counter ion and n is the number of counterions such that the total charge of the compound of formula (I) is zero, and wherein L is a 5-(5-bipyridin-2,2?-yl)-2,2?-bipyridine or derivative thereof. Methods of preparing the compounds and uses of the compounds to retain radiolabels are also presented.

Abstract: A radiation therapy system includes a radiation source capable of generating a beam of radiation; a magnetic resonance imaging (MRI) apparatus comprising at least one radiofrequency detector coil; and an electrically grounded dielectric material between the radiation source and the radiofrequency detector coil for shielding the at least one radiofrequency detector coil from the beam of radiation. Also disclosed is a radiofrequency detector coil for a magnetic resonance imaging (MRI) apparatus sheathed at least in part by a dielectric material that is adapted to be electrically grounded.

Abstract: Provided herein is a ligament ECM soluble fraction useful for the growth and regrowth of ligament tissue. Methods of preparation of the soluble fractions and use of the soluble fractions in growth or regrowth of ligament tissue also are provided.

Abstract: A computer-implemented method is provided for reducing artifacts in an MRI image as a result of radiation induced current in collector coils of an MRI apparatus. The method comprises the following steps. Selecting a plurality of pixels in a k-space image prior to generation of the MRI image. Analyzing each of the plurality of selected pixels to determine whether a pixel intensity is greater than a predefined global threshold. For each pixel having pixel intensity greater than the predefined global threshold, determining whether the pixel lies within a signal region of the k-space image or outside of the signal region of the k-space image. For each pixel that lies outside of the signal region, modifying the pixel intensity to be similar to a background pixel intensity, thereby creating a modified k-space image. Generating the MRI image based on the modified k-space image. A non-transitory computer readable medium and a radiation therapy system configured to implement the method are also provided.

Abstract: A computer-implemented method is provided for reducing artefacts in an MRI image as a result of radiation induced current in collector coils of an MRI apparatus. The method comprises the following steps. Selecting a plurality of pixels in a k-space image prior to generation of the MRI image. Analysing each of the plurality of selected pixels to determine whether a pixel intensity is greater than a predefined global threshold. For each pixel having pixel intensity greater than the predefined global threshold, determining whether the pixel lies within a signal region of the k-space image or outside of the signal region of the k-space image. For each pixel that lies outside of the signal region, modifying the pixel intensity to be similar to a background pixel intensity, thereby creating a modified k-space image. Generating the MRI image based on the modified k-space image. A non-transitory computer readable medium and a radiation therapy system configured to implement the method are also provided.

Abstract: A radiation therapy system includes a radiation source capable of generating a beam of radiation; a magnetic resonance imaging (MRI) apparatus comprising at least one radiofrequency detector coil; and an electrically grounded dielectric material between the radiation source and the radiofrequency detector coil for shielding the at least one radiofrequency detector coil from the beam of radiation. Also disclosed is a radiofrequency detector coil for a magnetic resonance imaging (MRI) apparatus sheathed at least in part by a dielectric material that is adapted to be electrically grounded.

Abstract: Compounds of the formula: where the formula variables are as defined herein, are disclosed that advantageously inhibit or block the biological activity of the HIV protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with the HIV virus. Intermediates and synthetic methods for preparing such compounds are also described.

Abstract: Compounds of the formula: where the formula variables are as defined herein, are disclosed that advantageously inhibit or block the biological activity of the HIV protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with the HIV virus. Intermediates and synthetic methods for preparing such compounds are also described.